Matinas BioPharma Holdings
Cash Flow
Last updated:
Cash flow statement presents a set of outflows and inflows of cash within a company through operating, investing and financing activities. Over the last year, operating activities of Matinas BioPharma Holdings generated cash of -$15,278,000, which is more than the previous year. Cash used in financing activities reached the amount of -$7,000 last year. Net change in cash is therefore -$2,043,000.
Cash Flow
| 2014 | -7.96M | -288.51K | 0 |
|---|---|---|---|
| 2015 | -7.81M | -5.42K | 8.45M |
| 2016 | -6.11M | 0 | 6.99M |
| 2017 | -11.45M | -942.18K | 15.60M |
| 2018 | -10.32M | -535.91K | 15.86M |
| 2019 | -14.09M | -6.01M | 29.85M |
| 2020 | -17.36M | -40.66M | 48.04M |
| 2021 | -15.22M | 16.77M | 6.96M |
| 2022 | -19.15M | 4.87M | 79K |
| 2023 | -15.27M | 13.24M | -7K |
MTNB Cash Flow Statement (2014 – 2023)
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | |
|---|---|---|---|---|---|---|---|---|---|---|
Cash at beginning of period | 7.08M | 21.28M | 12.76M | 22.75M | 13.00M | 7.99M | 4.10M | 3.22M | 2.59M | 10.84M |
Operating activities | ||||||||||
Net income | -22.94M | -20.99M | -23.28M | -22.44M | -17.37M | -14.08M | -15.48M | -7.59M | -9.13M | -10.22M |
| Adjustments to reconcile net income to cash generated by operating activities: | ||||||||||
Depreciation and amortization | 941K | 898K | 781.49K | 774.58K | 780.81K | 218.30K | 100.60K | 52.64K | 43.50K | 41.58K |
Stock-based compensation expense | 4.94M | 5.22M | 4.29M | 4.56M | 2.98M | 0 | 3.59M | 1.51M | 1.59M | 1.97M |
| Deferred income tax benefit | 4.94M | 5.22M | 4.29M | 4.56M | 2.98M | 0 | 3.59M | 1.51M | 1.59M | 1.97M |
| Changes in operating assets and liabilities: | ||||||||||
Accounts receivable, net | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 45.64K | 0 |
Inventories | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Accounts payable | -103K | -321K | 588.32K | -329.36K | 383.65K | -287.21K | 107.26K | -22.24K | -73.72K | -125.61K |
Cash generated by operating activities | -15.27M | -19.15M | -15.22M | -17.36M | -14.09M | -10.32M | -11.45M | -6.11M | -7.81M | -7.96M |
Investing activities | ||||||||||
Purchases Of Investments | 0 | -9.48M | -23.19M | -72.10M | -5.60M | 0 | 0 | 0 | 0 | 0 |
Investments In Property Plant And Equipment | -218K | -892K | -260.38K | -5.74K | -405.60K | -535.91K | -942.18K | 0 | -76.17K | -288.51K |
Acquisitions Net | 0 | -5.76M | -17.03M | 8.48M | 0 | 0 | 0 | 0 | 70.75K | 0 |
Cash generated by investing activities | 13.24M | 4.87M | 16.77M | -40.66M | -6.01M | -535.91K | -942.18K | 0 | -5.42K | -288.51K |
Financing activities | ||||||||||
Common Stock Issued | 0 | 99K | 6.99M | 48.10M | 30.10M | 0 | 1.12M | 7.15M | 10M | 0 |
Payments for dividends | 0 | 0 | 0 | 0 | -2.23B | 0 | -608.34M | 0 | 0 | 0 |
Repurchases of common stock | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Repayments of term debt | -7K | -20K | -30K | -54.67K | -81.71K | -59.18K | -17.13K | -160.22K | -48.39K | 0 |
Cash used in financing activities | -7K | 79K | 6.96M | 48.04M | 29.85M | 15.86M | 15.60M | 6.99M | 8.45M | 0 |
Net Change In Cash | -2.04M | -14.2M | 8.51M | -9.98M | 9.74M | 5.00M | 3.20M | 878.45K | 636.28K | -8.24M |
Cash at end of period | 5.03M | 7.08M | 21.27M | 12.76M | 22.75M | 13.00M | 7.30M | 4.10M | 3.22M | 2.59M |
| Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source |